Study to Evaluate the Immunogenicity and the Safety of an Adjuvanted Influenza Vaccine Candidate
Clinical trial NCT00363077 · COMPLETED
Trial details
- NCT number
- NCT00363077
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-10-02
- Primary completion
- 2006-11-01
- Enrollment
- 150
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.